Annual report
4452.TEDINET S100VFNW
Period2024-01-01 → 2024-12-31
Filed2025-03-21
StandardIFRS
ConsolidatedYes
Data checks19 of 19 passed
Key figures · 155
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.63T | 2024-01-01 → 2024-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.53T | 2023-01-01 → 2023-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.55T | 2022-01-01 → 2022-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.42T | 2021-01-01 → 2021-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.38T | 2020-01-01 → 2020-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥146.6bn | 2024-01-01 → 2024-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥60.0bn | 2023-01-01 → 2023-12-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥151.0bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥63.8bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥115.8bn | 2022-01-01 → 2022-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥150.0bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥174.0bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥107.8bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥43.9bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥86.0bn | 2022-01-01 → 2022-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥109.6bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥126.1bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥110.4bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥46.2bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss IFRS |
| Total assets | ¥1.87T | at 2024-12-31 | Cons. | Assets IFRS |
| Total assets | ¥1.77T | at 2023-12-31 | Cons. | Assets IFRS |
| Total assets | ¥1.73T | at 2022-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥1.70T | at 2021-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥1.67T | at 2020-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥768.4bn | at 2024-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥757.5bn | at 2023-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.10T | at 2024-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.01T | at 2023-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥995.4bn | at 2022-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥1.07T | at 2024-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥983.7bn | at 2023-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥972.1bn | at 2022-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥965.1bn | at 2021-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥923.7bn | at 2020-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥357.7bn | at 2024-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥291.7bn | at 2023-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥268.2bn | at 2022-12-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥336.1bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥353.2bn | at 2020-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥201.6bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥202.5bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥130.9bn | 2022-01-01 → 2022-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥175.5bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥214.7bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥45.9bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥109.3bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥74.9bn | 2022-01-01 → 2022-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥67.2bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥61.9bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥104.6bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥80.0bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥139.3bn | 2022-01-01 → 2022-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥141.6bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥87.1bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥231.94 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥94.37 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥183.28 | 2022-01-01 → 2022-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥230.59 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥262.29 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥94.37 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥183.27 | 2022-01-01 → 2022-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥230.57 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥262.25 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥2,296.69 | at 2024-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥2,116.01 | at 2023-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥2,091.2 | at 2022-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥2,036.66 | at 2021-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,920.56 | at 2020-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 57.1% | at 2024-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 55.6% | at 2023-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 56.3% | at 2022-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 56.6% | at 2021-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 55.5% | at 2020-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 10.5% | 2024-01-01 → 2024-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 4.5% | 2023-01-01 → 2023-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 8.9% | 2022-01-01 → 2022-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 11.6% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 14.2% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 32,566 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 34,257 | at 2023-12-31 | Cons. | Number of employees |
| Employees | 35,411 | at 2022-12-31d | Cons. | Number of employees |
| Employees | 33,507 | at 2021-12-31d | Cons. | Number of employees |
| Employees | 33,409 | at 2020-12-31d | Cons. | Number of employees |
| Revenue | ¥898.1bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥868.1bn | 2023-01-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥871.7bn | 2022-01-01 → 2022-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥872.9bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥897.2bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥62.9bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Operating income | ¥29.8bn | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Ordinary income | ¥104.4bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥47.6bn | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥99.2bn | 2022-01-01 → 2022-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥135.6bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥153.3bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥110.1bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥27.7bn | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Net income | ¥91.7bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥28.0bn | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | ¥79.1bn | 2022-01-01 → 2022-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥101.6bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥116.3bn | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.29T | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥1.24T | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥1.21T | at 2022-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.26T | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.29T | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥565.0bn | at 2024-12-31 | Standalone | Liabilities |
| Total liabilities | ¥532.8bn | at 2023-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥726.3bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥707.0bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥747.9bn | at 2022-12-31d | Standalone | Net assets |
| Net assets / equity | ¥787.6bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥805.9bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥140.5bn | at 2024-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥118.3bn | at 2023-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥197.22 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.17 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥168.37 | 2022-01-01 → 2022-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥213.52 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥241.47 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥60.17 | 2023-01-01 → 2023-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥168.36 | 2022-01-01 → 2022-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥213.5 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥241.43 | 2020-01-01 → 2020-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥152 | 2024-01-01 → 2024-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥150 | 2023-01-01 → 2023-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥148 | 2022-01-01 → 2022-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥144 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥140 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,561.67 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,518.89 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,606.78 | at 2022-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,659.61 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,673.01 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 56.2% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.0% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.8% | at 2022-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.3% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.2% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 12.8% | 2024-01-01 → 2024-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.8% | 2023-01-01 → 2023-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.3% | 2022-01-01 → 2022-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.8% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.9% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 465,900,000 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 465,900,000 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 465,900,000 | at 2022-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 475,000,000 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 482,000,000 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 7,861 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 8,199 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 8,403 | at 2022-12-31d | Standalone | Number of employees |
| Employees | 8,508 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 8,112 | at 2020-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2024-01-01 → 2024-12-31 | ¥1.1bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-12-31 | −¥823m |
| Chemical Businessreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥28.4bn |
| Chemical Businessreportable segment | employees | at 2024-12-31 | 3969 pure |
| Chemical Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥34.6bn |
| Consumer Products Businessreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥64.1bn |
| Consumer Products Businessreportable segment | employees | at 2024-12-31 | 27587 pure |
| Consumer Products Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥112.8bn |
| Cosmetics Businessreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥15.1bn |
| Cosmetics Businessreportable segment | employees | at 2024-12-31 | 9804 pure |
| Cosmetics Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | −¥3.7bn |
| Health And Beauty Care Businessreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥18.6bn |
| Health And Beauty Care Businessreportable segment | employees | at 2024-12-31 | 7859 pure |
| Health And Beauty Care Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥34.4bn |
| Hygiene And Living Care Businessreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥28.4bn |
| Hygiene And Living Care Businessreportable segment | employees | at 2024-12-31 | 8954 pure |
| Hygiene And Living Care Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥75.8bn |
| Life Care Businessreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥1.9bn |
| Life Care Businessreportable segment | employees | at 2024-12-31 | 970 pure |
| Life Care Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥6.3bn |
| —segment total | capex | 2024-01-01 → 2024-12-31 | ¥92.5bn |
| —segment total | segment profit | 2024-01-01 → 2024-12-31 | ¥147.5bn |
| Reconciling Itemsreconciling | capex | 2023-01-01 → 2023-12-31 | ¥1.7bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-12-31 | −¥13.4bn |
| Chemical Businessreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥22.9bn |
| Chemical Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥23.6bn |
| Consumer Products Businessreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥68.5bn |
| Consumer Products Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥49.9bn |
| Cosmetics Businessreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥12.5bn |
| Cosmetics Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | −¥5.4bn |
| Health And Beauty Care Businessreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥18.8bn |
| Health And Beauty Care Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥40.5bn |
| Hygiene And Living Care Businessreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥32.7bn |
| Hygiene And Living Care Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥20.1bn |
| Life Care Businessreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥4.6bn |
| Life Care Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | −¥5.3bn |
| —segment total | capex | 2023-01-01 → 2023-12-31 | ¥91.4bn |
| —segment total | segment profit | 2023-01-01 → 2023-12-31 | ¥73.5bn |
| Chemical Businessreportable segment | employees | at 2024-12-31 | 1278 pure |
| Consumer Products Businessreportable segment | employees | at 2024-12-31 | 5646 pure |
| Cosmetics Businessreportable segment | employees | at 2024-12-31 | 1337 pure |
| Health And Beauty Care Businessreportable segment | employees | at 2024-12-31 | 1897 pure |
| Hygiene And Living Care Businessreportable segment | employees | at 2024-12-31 | 2264 pure |
| Life Care Businessreportable segment | employees | at 2024-12-31 | 148 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,150
| Item | Context | Value | Unit |
|---|---|---|---|
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 89200 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.0002 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 89200 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 89200 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.0002 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 35402000000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 76 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row2Member | 35402000000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row2Member | 76 | |
| Number of male directors and other officers | FilingDateInstant | 9 | |
| Number of female directors and other officers | FilingDateInstant | 5 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.357 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00883-000HasebeYoshihiroMember | 18000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00883-000NegoroMasakazuMember | 12400 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00883-000NishiguchiToruMember | 17800 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00883-000LisaMacCallumMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00883-000ShinobeOsamuMember | 3100 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00883-000SakuraiErikoMember | 500 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00883-000NishiiTakaakiMember | 4000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00883-000TakashimaMakotoMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00883-000SarahLCasanovaMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00883-000WadaYasushiMember | 14700 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00883-000MurataMamiMember | 1500 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00883-000OkaNobuhiroMember | 4500 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00883-000AraiSaekoMember | 200 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00883-000NaitoJunyaMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 76700 | |
| Audit fees reporting company | Prior1YearDuration | 157000000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | 39000000 | JPY |
| Audit fees reporting company | CurrentYearDuration | 156000000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | 3000000 | JPY |
| Audit fees consolidated subsidiaries | Prior1YearDuration | 64000000 | JPY |
| Non audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Audit fees consolidated subsidiaries | CurrentYearDuration | 62000000 | JPY |
| Non audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Audit fees total | Prior1YearDuration | 221000000 | JPY |
| Non audit fees total | Prior1YearDuration | 39000000 | JPY |
| Audit fees total | CurrentYearDuration | 218000000 | JPY |
| Non audit fees total | CurrentYearDuration | 3000000 | JPY |
| Audit fees reporting company network firms | Prior1YearDuration | － | JPY |
| Non audit fees reporting company network firms | Prior1YearDuration | 36000000 | JPY |
| Audit fees reporting company network firms | CurrentYearDuration | － | JPY |
| Non audit fees reporting company network firms | CurrentYearDuration | 49000000 | JPY |
| Audit fees consolidated subsidiaries network firms | Prior1YearDuration | 613000000 | JPY |
| Non audit fees consolidated subsidiaries network firms | Prior1YearDuration | 119000000 | JPY |
| Audit fees consolidated subsidiaries network firms | CurrentYearDuration | 678000000 | JPY |
| Non audit fees consolidated subsidiaries network firms | CurrentYearDuration | 139000000 | JPY |
| Audit fees total network firms | Prior1YearDuration | 613000000 | JPY |
| Non audit fees total network firms | Prior1YearDuration | 155000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 19 of 19 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |